Authors: Jouanneau, E Alberti, L Nejjari, M Treilleux, I Vilgrain, I Duc, A Combaret, V Favrot, M Leboulch, P Bachelot, T

Citation: E. Jouanneau et al., Lack of antitumor activity of recombinant endostatin in a human neuroblastoma xenograft model, J NEURO-ONC, 51(1), 2001, pp. 11-18

Authors: Vandesompele, J Speleman, F Van Roy, N Laureys, C Brinkschmidt, C Christiansen, H Lampert, F Lastowska, M Bown, N Pearson, A Nicholson, JC Ross, F Combaret, V Delattre, O Feuerstein, BC Plantaz, D

Citation: J. Vandesompele et al., Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?, MED PED ONC, 36(1), 2001, pp. 5-10

Authors: Plantaz, D Vandesompele, J Van Roy, N Lastowska, M Bown, N Combaret, V Favrot, MC Delattre, O Michon, J Benard, J Hartmann, O Nicholson, JC Ross, FM Brinkschmidt, C Laureys, G Caron, H Matthay, KK Feuerstein, BG Speleman, F

Citation: D. Plantaz et al., Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11Q deletion in tumors lacking MYCN amplification, INT J CANC, 91(5), 2001, pp. 680-686

Authors: Thiesse, P Hany, MA Combaret, V Renchere-Vince, D Bouffet, E Bergeron, C

Citation: P. Thiesse et al., Assessment of percutaneous fine needle aspiration cytology as a technique to provide diagnostic and prognostic information in neuroblastoma, EUR J CANC, 36(12), 2000, pp. 1544-1551

Authors: Frappaz, D Michon, J Coze, C Berger, C Plouvier, E Lasset, C Bernard, JL Stephan, JL Bouffet, E Buclon, M Combaret, V Fourquet, A Philip, T Zucker, JM

Citation: D. Frappaz et al., LMCE3 treatment strategy: Results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis, J CL ONCOL, 18(3), 2000, pp. 468-476

Authors: Tchirkov, A Kanold, J Combaret, V Philip, I Kwiatkowski, F Malet, P Demeocq, F

Citation: A. Tchirkov et al., Immunological and molecular detection of tumor contamination in leukapheresis products from children with disseminated neuroblastoma: implication forevaluation of tumor cell depletion after CD34 selection, BONE MAR TR, 24(2), 1999, pp. 229-230